Related Experiment Video
Updated: May 25, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
[Supra-His complete atrioventricular block in a patient with subclinical hyperthyroidism]
Basri Amasyalı1, Cem Barçın, Ayhan Kılıç
1Department of Cardiology, Haydarpaşa Training Hospital, Gülhane Military Medical School, İstanbul, Turkey. dramasyali@yahoo.com
Abstract:
Subclinical hyperthyroidism is a difficult entity to diagnose because of silent clinical features and it may be easily underdiagnosed unless it is suspected and thyroid hormone levels are examined. Although atrioventricular (AV) conduction abnormalities such as complete heart block may occasionally be seen in hyperthyroidism, its association with subclinical hyperthyroidism has not been reported previously. We report on a 50-year-old female patient who did not have any systemic or cardiovascular disease or history of drug use that could affect AV conduction and presented with presyncope and complete heart block with narrow QRS complexes. Thyroid function tests showed subclinical hyperthyroidism and an electrophysiological study showed the supra-His level as the site of complete AV block. After initiation of antithyroid treatment (propylthiouracil), the patient's rhythm improved to second-degree AV block on the third day and returned to normal sinus rhythm on the fourth day.
More Related Videos
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Hyperthyroidism II: Pathophysiology
Hyperthyroidism I: Introduction
Hypothyroidism II: Pathophysiology
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Graves Disease II: Pathophysiology